Graham Lidgard
Corporate Officer/Principal presso EXACT SCIENCES CORPORATION
Profilo
Graham Peter Lidgard ha fondato Matritech, Inc. Il Dr. Lidgard è Chief Science Officer, SVP-Research & Development alla EXACT Sciences Corp. Nella sua carriera passata ha ricoperto la posizione di vicepresidente senior di ricerca e sviluppo alla Ngen, Inc., vicepresidente di ricerca e sviluppo alla Gen-Probe, Inc., vicepresidente di sviluppo del prodotto alla Matritech, Inc. e vicepresidente di sviluppo del prodotto alla Ciba Corning Diagnostics Corp. Il Dr. Lidgard ha conseguito una laurea e un dottorato presso l'Università di Manchester.
Posizioni attive di Graham Lidgard
Società | Posizione | Inizio |
---|---|---|
EXACT SCIENCES CORPORATION | Corporate Officer/Principal | 01/04/2021 |
Precedenti posizioni note di Graham Lidgard
Società | Posizione | Fine |
---|---|---|
NGEN INC | Chief Tech/Sci/R&D Officer | 10/08/2009 |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/06/2002 |
NANOGEN INC | Chief Tech/Sci/R&D Officer | - |
Ciba Corning Diagnostics Corp. | Corporate Officer/Principal | - |
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Founder | - |
Formazione di Graham Lidgard
The University of Manchester | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
EXACT SCIENCES CORPORATION | Health Technology |
Aziende private | 5 |
---|---|
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Health Technology |
Ngen, Inc.
Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Ciba Corning Diagnostics Corp. | |
NANOGEN INC |
- Borsa valori
- Insiders
- Graham Lidgard